RedHill Biopharma Ltd.
RDHL · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,067 | -$2,067 | -$2,590 | -$2,590 |
| Dep. & Amort. | $84 | $84 | $101 | $101 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $149 | $149 | $218 | $218 |
| Change in WC | -$145 | -$145 | $452 | $452 |
| Other Non-Cash | -$529 | -$529 | $228 | $228 |
| Operating Cash Flow | -$2,508 | -$2,508 | -$1,592 | -$1,592 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$2 | -$4 | -$4 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$2 | -$2 | -$4 | -$4 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,630 | $1,630 | $259 | $259 |
| Financing Cash Flow | $1,630 | $1,630 | $259 | $259 |
| Forex Effect | $5 | $5 | $8 | $8 |
| Net Chg. in Cash | $0 | $0 | $0 | -$7,277 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $0 | $0 | $0 |
| End Cash | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2,509 | -$2,509 | -$1,596 | -$1,596 |